Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kodiak Sciences Inc (KOD)

Kodiak Sciences Inc (KOD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,488,527
  • Shares Outstanding, K 53,048
  • Annual Sales, $ 0 K
  • Annual Income, $ -176,210 K
  • EBIT $ -223 M
  • EBITDA $ -196 M
  • 60-Month Beta 2.67
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 61.80

Options Overview Details

View History
  • Implied Volatility 151.79% (+18.10%)
  • Historical Volatility 80.90%
  • IV Percentile 69%
  • IV Rank 24.85%
  • IV High 422.80% on 03/21/25
  • IV Low 62.19% on 09/08/25
  • Expected Move (DTE 3) 3.71 (13.21%)
  • Put/Call Vol Ratio 1.74
  • Today's Volume 225
  • Volume Avg (30-Day) 296
  • Put/Call OI Ratio 0.54
  • Today's Open Interest 6,266
  • Open Int (30-Day) 5,673
  • Expected Range 24.35 to 31.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -1.03
  • Number of Estimates 4
  • High Estimate -0.86
  • Low Estimate -1.17
  • Prior Year -0.84
  • Growth Rate Est. (year over year) -22.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.50 +30.51%
on 12/16/25
31.18 -10.01%
on 12/24/25
+4.25 (+17.85%)
since 12/12/25
3-Month
10.94 +156.49%
on 10/14/25
31.18 -10.01%
on 12/24/25
+16.19 (+136.39%)
since 10/10/25
52-Week
1.92 +1,361.46%
on 04/09/25
31.18 -10.01%
on 12/24/25
+19.74 (+237.26%)
since 01/10/25

Most Recent Stories

More News
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference

PALO ALTO, Calif. , Jan. 7, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing...

KOD : 28.06 (+1.23%)
Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares

PALO ALTO, Calif. , Dec. 18, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing...

KOD : 28.06 (+1.23%)
Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock

PALO ALTO, Calif. , Dec. 16, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing...

KOD : 28.06 (+1.23%)
Kodiak Sciences Announces Proposed Public Offering of Common Stock

PALO ALTO, Calif. , Dec. 15, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing...

KOD : 28.06 (+1.23%)
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results

PALO ALTO, Calif. , Nov. 13, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ended September 30, 2025....

KOD : 28.06 (+1.23%)
Kodiak Sciences to Present at Upcoming Investor Conferences

PALO ALTO, Calif. , Nov. 12, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing...

KOD : 28.06 (+1.23%)
Stocks Settle Mostly Higher on Government Reopening Optimism

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.31%. December E-mini...

AMAT : 307.24 (+2.01%)
AVGO : 352.21 (+2.10%)
MRK : 109.19 (-1.21%)
RGTI : 25.53 (+3.28%)
$IUXX : 25,787.66 (+0.08%)
AMGN : 325.54 (-0.17%)
PFE : 25.27 (-0.82%)
ELV : 374.97 (+0.57%)
ASML : 1,281.23 (+0.58%)
ZNH26 : 112-025 (-0.06%)
CRWV : 89.93 (+12.22%)
VRTS : 175.63 (+1.09%)
Dow and S&P Rise as Nasdaq Faces Selling Pressure

The S&P 500 Index ($SPX ) (SPY ) today is up +0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.19%. US stock indexes are mixed...

AMAT : 307.24 (+2.01%)
AVGO : 352.21 (+2.10%)
RKLB : 87.90 (+3.59%)
RGTI : 25.53 (+3.28%)
$IUXX : 25,787.66 (+0.08%)
ASML : 1,281.23 (+0.58%)
ZNH26 : 112-025 (-0.06%)
CRWV : 89.93 (+12.22%)
PSKY : 12.15 (+0.75%)
SRDX : 42.98 (+0.35%)
LRCX : 220.40 (+0.93%)
AMD : 207.69 (+2.22%)
Stocks Pressured by AI Jitters and Signs of US Labor Market Weakness

The S&P 500 Index ($SPX ) (SPY ) today is down -0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.42%. December E-mini S&P futures...

AMAT : 307.24 (+2.01%)
RKLB : 87.90 (+3.59%)
RGTI : 25.53 (+3.28%)
$IUXX : 25,787.66 (+0.08%)
ZNH26 : 112-025 (-0.06%)
CRWV : 89.93 (+12.22%)
ESH26 : 7,006.00 (-0.15%)
PSKY : 12.15 (+0.75%)
SRDX : 42.98 (+0.35%)
LRCX : 220.40 (+0.93%)
VSAT : 40.42 (-0.96%)
$DOWI : 49,590.20 (+0.17%)
Follow-up data for Kodiak's KSI-101 from the APEX study showed continued strengthening of clinical effect (≥90% of patients achieving absence of intraretinal and subretinal fluid) through week 20 in macular edema secondary to inflammation (MESI)

PALO ALTO, Calif. , Nov. 5, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing...

KOD : 28.06 (+1.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Kodiak Sciences Inc. is a clinical stage biopharmaceutical company engaged in developing novel therapeutics to treat chronic, high-prevalence retinal diseases, which are the major causes of blindness. The company's proprietary antibody biopolymer conjugate (ABC) platform is designed to maintain potent...

See More

Key Turning Points

3rd Resistance Point 32.03
2nd Resistance Point 30.11
1st Resistance Point 29.08
Last Price 28.06
1st Support Level 26.13
2nd Support Level 24.21
3rd Support Level 23.18

See More

52-Week High 31.18
Last Price 28.06
Fibonacci 61.8% 20.00
Fibonacci 50% 16.55
Fibonacci 38.2% 13.10
52-Week Low 1.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar